RNASEH1 and non-small cell lung carcinoma: RNASEH1‐AS1 accelerated the malignant progression of NSCLC cells, and its effects on promoting NSCLC progression were achieved by sequestering miR‐516a‐5p and overexpressing FOXK1, which, in turn, activated the Wnt/β‐catenin pathway.